Investor Alert: Robbins LLP Informs Investors of the Tenax Therapeutics, Inc. Class Action Lawsuit

Posted on by sHq_LoGiNz

SAN DIEGO–(BUSINESS WIRE)—- $TENX #TENX–The complaint alleges that Tenax Therapeutics, Inc. misled investors regarding the viability of its drug candidate levosimendan.

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.